Protein-Protein Interaction Modulators for Epigenetic Therapies.

Area of Science:

• Drug discovery and development
• Epigenetics
• Medicinal chemistry

Background:

• Protein-protein interactions (PPIs) are increasingly targeted for drug discovery.
• Epitargets, often elusive to traditional drugs, represent a significant challenge.
• Peptides and peptidomimetics are suitable for modulating PPIs due to their chemical nature.

Purpose of the Study:

• To review the current landscape of targeting PPIs in epigenetic drug discovery.
• To highlight the potential of peptides and peptide-like compounds as therapeutic agents.

Main Methods:

• Literature review focusing on PPIs and epigenetic targets.
• Analysis of peptide-based drug discovery strategies.
• Discussion of challenges and opportunities in peptide drug development.

Main Results:

• Peptide-based approaches are viable for targeting PPIs, including those in epigenetics.
• Peptides offer a unique modality for addressing difficult-to-drug targets.
• Despite historical challenges, peptide drug discovery is a valid and advancing strategy.

Conclusions:

• Peptides and peptide-like molecules are valuable candidates for epigenetic drug discovery targeting PPIs.
• Further research into peptide-based therapeutics is warranted for challenging targets.
• The field of epigenetic drug discovery benefits from exploring novel chemical modalities like peptides.